Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells
暂无分享,去创建一个
L. Bourguignon | D. Zhu | D Zhu | C F Welsh | L Y Bourguignon | C. Welsh
[1] C. Underhill,et al. CD44: the hyaluronan receptor. , 1992, Journal of cell science.
[2] L. Bourguignon,et al. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. , 1991, The Journal of biological chemistry.
[3] L. Wahl,et al. Dual role of the CD44 molecule in T cell adhesion and activation. , 1989, Journal of immunology.
[4] J. Gustafsson,et al. Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP‐r , 1985, The Prostate.
[5] L. Bourguignon,et al. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin , 1992, Molecular and cellular biology.
[6] Brian Seed,et al. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family , 1989, Cell.
[7] P. Herrlich,et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps , 1993, The Journal of cell biology.
[8] G. Screaton,et al. CD44 and cancer screening , 1993, The Lancet.
[9] L. Bourguignon,et al. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. , 1989, The Journal of biological chemistry.
[10] Erwin G. Van Meir,et al. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. , 1993, Cancer research.
[11] W. Carter,et al. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons , 1991, The Journal of cell biology.
[12] Martin Hofmann,et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.
[13] C. Meijer,et al. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). , 1990, Leukemia.
[14] S. Jalkanen,et al. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin , 1992, The Journal of cell biology.
[15] J. Bell,et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[16] William,et al. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. , 1988, The Journal of biological chemistry.
[17] L. Ellis,et al. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases , 1993, The Lancet.
[18] X. Chen,et al. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. , 1993, Journal of immunology.
[19] P. Herrlich,et al. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. , 1994, Cancer research.
[20] P. Herrlich,et al. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. , 1993, Cancer research.
[21] L. Bourguignon,et al. Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. , 1991, The Journal of biological chemistry.
[22] D. Tarin,et al. Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.
[23] C. Figdor,et al. De-novo expression of CD44 and survival in gastric cancer , 1993, The Lancet.
[24] R. Chiu,et al. Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1. , 1994, The Journal of biological chemistry.
[25] L. Bourguignon,et al. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function , 1994, The Journal of cell biology.
[26] I. Stamenkovic,et al. CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.
[27] D. S. Coffey. Prostate cancer. An overview of an increasing dilemma , 1993, Cancer.
[28] J. R. de los Toyos,et al. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells , 1987, The Journal of cell biology.
[29] R. Idzerda,et al. Expression of CD44 confers a new adhesive phenotype on transfected cells , 1990, Cell.
[30] R. Ostenson,et al. Human primary prostate tumor cell line, ALVA‐31: A new model for studying the hormonal regulation of prostate tumor cell growth , 1993, The Prostate.
[31] M. Amiot,et al. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.
[32] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[33] L. Bourguignon,et al. New CD44 splice variants associated with human breast cancers , 1995, Journal of cellular physiology.
[34] George L. Wright,et al. Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma , 1989, International journal of cancer.
[35] G. Murphy,et al. LNCaP model of human prostatic carcinoma. , 1983, Cancer research.
[36] V. Bennett,et al. Human erythrocyte ankyrin. Purification and properties. , 1980, The Journal of biological chemistry.
[37] S. Kumar,et al. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. , 1989, Experimental cell research.
[38] J. R. de los Toyos,et al. Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. , 1989, Journal of immunology.
[39] J. Bishop,et al. Expression of CD44 is repressed in neuroblastoma cells , 1991, Molecular and cellular biology.
[40] L. Bourguignon,et al. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin , 1988, The Journal of cell biology.
[41] C. Figdor,et al. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. , 1990, Journal of immunology.
[42] E. Metter,et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. , 1992, JAMA.